Bizengri

Active Ingredient(s): Zenocutuzumab-zbco
FDA Approved: * December 4, 2024
Pharm Company: * MERUS N.V.
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Bizengri 20 mg/ml Intravenous Injection
NDC: 71837-1000
Labeler:
Partner Therapeutics, Inc.
Bizengri 20 mg/ml Intravenous Injection
NDC: 83077-100
Labeler:
Merus Us, Inc.